NCI/CIRB S1505 A Randomized Phase II Study of Perioperative mFOLFIRINOX versus Gemcitabine/nab-Paclitaxel as Therapy for Resectable Pancreatic Adenocarcinoma

BH16-202
Cancer - Pancreatic, Cancer
Chandravathi Loke, MD
Damour Center for Cancer Care
Resectable Pancreatic Adenocarcinoma
Betsy Lopez
413-794-4154